Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still trending in the direction I like to see!
As acb said, medical first for many! https://www.forbes.com/sites/dariosabaghi/2022/07/27/switzerland-fully-legalizes-medical-cannabis-and-allows-export/
I don't understand how that can be?
The sub-sub penny stock people say this is a "top choice" and there is "a rumor of a buy out" and the "price target has been raised." And let's not forget the famous "breakout alert".
Getting close to flip time again on this pathetic stock because it always make a short term move in cohoots with news on another pot stock like Tilray or something but it's always short lived.
Great news. Of course, it should also be mentioned that they had just lowered their target from C$4.00.
Of course, it was Cowen who continually recommended buying ACB as it plummeted. Most people didn't recognize that it was Cowen who got a cut of all the placements and dilutions. They benefitted by the share's massive descent.
Details matter
https://www.marketbeat.com/instant-alerts/tse-acb-a-buy-or-sell-right-now-2022-07/
Simon loves to buy duds... lol
Aurora Cannabis Inc Price Target Raised to C$2.00/Share From C$1.85 by Cowen & Co $ACB
House-passed NDAA includes banking provisions for cannabis
https://www.bankingdive.com/news/house-passed-ndaa-includes-banking-provisions-for-cannabis/627485/ $ACB
One example:
March 15, 2022: $2.97 USD
April 15, 2022: $3.67
BILL
2. S.4591 — 117th Congress (2021-2022)
A bill to decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide expungement of certain cannabis offenses, and for other purposes.
Sponsor: Sen. Booker, Cory A. [D-NJ] (Introduced 07/21/2022) Cosponsors: (4)
Committees: Senate - Finance
Latest Action: Senate - 07/21/2022 Read twice and referred to the Committee on Finance. (All Actions)
What charting system are you using? I remember it going sideways but don't recall it going up over a monthly range this year Yeah, adjusting ebita can be deceptive imo too, but hopefully what's recorded are the big concerns most of the institutions want to see. I did read things like bonus(s) don't need to be included for example.
ACB has trended up over a month many times. The last time was March-April of this year. The price has always, without exception, then crashed.
We'll see on the EBITDA positive stuff. But you know my opinion on that.
As for buyouts, breakouts, etc.. the sub-sub penny stock players like to try that stuff hoping to get out of their bad purchases. They are rarely correct and a broken clock has been more accurate.
I cannot remember the last time we trended up over a month's time frame. Hopefully we make it to to the 3 month with this trend..and beyond!. I believe they will be ebita positive. Just concerned about any "adjusted" ebita positive because what might get left out might piss off investors. As for any "rumor" of a buyout, I'd be interested for that person to point to where this rumor is brought up as I would like to read it myself.
$ACB Here comes $2's
Maybe the rumor of a buy out is true?
ACB is a top choice, among people shorting these Canadian LP's into oblivion.
Aurora Cannabis will always be the top choice, and a top among the top performers...!.
Most cannabis/hemp/cbd stocks will grow into big companies and the sector breakout rally is due any day!...with or without legalization bullshit, cannabis stocks will raise to its all time high ....!.
Good point however after the HEXO debacle, I think Simon will be out of money and struggling to keep TLRY afloat. What a dumb move on his part.
Tilly might buy them , he bought Hexo after all. Simon has Global Dominance Ideations....
Very few of these Canadian LP's will survive the next 6 to 12 months without US legalization. I dont think ACB is one of them without an R/S or merger.
See you under a buck
What happens when the elephant in the room is the room itself?
That question for investors in Aurora Cannabis was finally answered with news this last quarter that its massive state-of-the-art Sky greenhouse outside Edmonton would be shuttered in the fall.
Announced with great fanfare in 2018, the 800,000 sq. foot Sky facility was designed to be as close to automated as you can get, estimated to be capable of producing as much as 8,000 kg of cannabis per month in 17 production rooms.
But by the time production started in 2019, with a price tag of well over $100 million, the Canadian cannabis production market was already over capacity with consumer tastes moving rapidly toward the hand-produced craft segment that is everything the Sky facility is not.
While they didn’t talk about it on investor conference calls, it was long rumoured Aurora found out the hard way what legacy growers had known for decades — scaling it up always comes with problems and the more you scale it up, the bigger the problems.
By the time its closure was announced last month, Sky was operating at 25 percent capacity and a victim of its own size, a behemoth unable to respond to constantly shifting consumer demands at a competitive price.
“Sky was originally created… to be one of the largest global, almost completely automated facilities to grow what I would call mid-tier flower,” Aurora CEO Miguel Martin told investors during the last Q3 call. “As the consumer evolved very quickly, bud quality, density, moisture, all of those things [we found] does not lend itself to automation…”
Success, as some say, has a thousand fathers while failure is an orphan. Aurora did not respond to interview requests.
Neither did Canopy when asked similar questions about the demise of its equally ambitious Tweed Farms greenhouse facility in southern Ontario or in British Columbia.
This is not to pick on either company in particular, it’s just that they are some of the most recent examples of big cannabis plays from the early days of legalization failing to come to fruition.
If Canada’s big players don’t have the answer, who knows what it takes to pull off a high-quality cannabis crop at a competitive price at volumes that could allow national sales?
While technology doesn’t hurt, it turns out the answer may be just old-school experience. And it doesn’t come from any of the big names.
It’s hard to quantify success in the recreational cannabis market fully, but Pure Sunfarms of Delta BC surely comes close.
At Pure Sunfarms, success doesn’t have a thousand fathers but rather about 800 employees operating primarily out of two 1.1 million square foot hybrid greenhouses located across the street from each other.
CEO Mandesh Dosanj says the facility is currently operating at three-quarters capacity, growing into the facility as part of a carefully planned expansion.
“We’ve never laid off an employee,” Dosanjh adds, pointing to 14 straight quarters of profitability for the publicly listed company as another sign it is doing something right.
He knows full well that part of the company’s success lies in the hybrid greenhouse model, where if done right, the higher cost and quality of indoor meets the lower cost and output of outdoor-grown cannabis.
But Dosanjh says a greenhouse is not the only factor, giving credit to the years of produce-growing experience parent company Village Farms brought to the table, long before they saw their first cannabis plant.
“We have hundreds of years of experience, first with fresh-cut flowers in the early days and then we pivoted to produce,” Dosanjh adds. “We put together an incredible team. We knew high-tech greenhouses, but we were smart enough to bring in the legacy folks.”
Dosanjh doesn’t gloat over Aurora’s difficulties but lays clear what he thinks the problems are with it and other ‘Big Canna’ players.
“In the early days, it was all about telling and selling the growth story in order to get to more capital markets, to raise share prices,” he says. “People thought they could build this defensive moat with these massive facilities. I know they ran into significant yield and quality issues where the products they were growing just weren’t worth it.”
But rather than admit they can’t scale it up, Dosanjh says the bigger companies claim inventory issues. “That’s why you see a lot of talk of inventory build-up with these organizations,” he adds.
Jamie D’Alimonte, CEO of Greenway Greenhouse Cannabis Corporation, had no problem dissecting the demise of Aurora Sky.
“I wouldn’t have started with 20 acres,” he says. “And why did they plant it all so fast? The funds were raised; why spend it right away?”
“I don’t fault the early movers for doing what they did, but they didn’t consult with the right people, the proper large-scale growers,” he says. “Cannabis is an expensive crop to grow, lots of labour and regulations. Had they started slowly, maybe Sky could have succeeded.”
D’Alimonte might just be being polite.
His recent success and that of partner and uncle Carl Mastronardi is also born of long experience growing hydroponic produce in a company first established by D’Alimonte’s immigrant grandparents.
Greenway employs a staff of 18 at two separate facilities in Essex County, ON. One facility is dedicated to propagation and the other to flower production and packaging.
The two facilities operate under different licenses and help with plant quarantine. Plants are put through the vegetative cycle at the nursery before transfer to the flower facility and one of its eight smaller growing rooms.
“The plants arrive raring to go,” D’Alimonte adds.
Growing cannabis only for just over a year, Greenway already routinely pulls 200-300 kg of cannabis per room.
D’Alimonte says their success within that facility lies in adopting tactics from the legacy growers who have long found better yields by stringing together a bunch of smaller rooms rather than running one big one.
“We’ve chosen to do that, to mimic the small-scale approach,” he adds.
And you can only take away so much of the human touch.
“Cannabis plants can’t be moved around, and there’s only so much that can be automated,” he declares. “The only automation we see is in the back end and packaging.”
The facility also includes independently controlled rooms and backup systems for just about everything.
“When growing crops you have to make sure your systems are all in place and are reliable,” D’Alimonte says. “Your location, your staff, all have to be top notch. Plants have needs that cannot be denied.”
Sustainable growth has been one of the hallmarks of the parent company’s decades-long success, he adds, but demand for their product has them already planning to scale up to two more 50,000 sq. ft. facilities.
As a final lesson, Pure Sunfarms’ Dosanjh says to understand your market as it is, not as you want it to be.
“The consumer is the heart of the market. We went to the heart of the market to understand the cannabis consumer as they are today,” he explains.
“In that context, we didn’t build a business upon the future; we built it on the regs currently in play, unlike a lot of companies who are asking government to change the rules to save their business.”
I'm all for going up. I think we have to wait for something like Germany to finalize along with confirmation we did achieve positive EBITDA. As for Adjusted EBITDA if they claim that,, it would be interesting to know what they didn't include..like maybe their bonuses.
Gap fill is due:$1.63 to 2.52!, the next move takes ACB closer to 1.60s and then gap fill a significant move to turn this a long term bull!..its coming soon!
For sure. Short Aurora... it was an easy short 4 years ago also
Noooo. In past few years this company owes so much money to shareholders and banks... this will head lower.. my call is on bankruptcy sometime in the future
Hopefully thing things are turned around. The 12% layoff could be explained with the sky facility closing and thrive aquasition. I'm not saying we go down or up after this next earnings, but I do hope we go up.
licensed producer aurora cannabis
SHORTING AURORA AGAIN
BONNOJULY 6, 2022
In 2018, I suggested shorting Aurora. Bad advice, many thought, on the eve of legalization when licensed producer stocks rose.
But the foundation of Canada’s LP system is flawed. In 2022, this is apparent. You made money if you shorted Aurora before the cannabis bubble popped.
The question is now: is Aurora now worth buying on the dip?
Shorting Aurora Again
Aurora Cannabis is one of the worst-performing stocks out there. When I suggested shorting Aurora the first time, the company had announced the acquisition of MedReleaf for over $2.5 billion.
Today, Aurora’s total market cap isn’t even worth that much. Back then, their value was $7.4-billion. Aurora’s market cap in 2022 is $400 million.
Far from being Canada’s number one supplier of cannabis, they are Canada’s biggest LP loser. From billions to millions, Aurora has lost well over 95% of its value since 2018, when I first suggest investors short the stock.
(Shorting stock involves selling batches of stock to make a profit, then repurchasing it cheaply when the price goes down.)
Will Aurora crash even further, or is it time to buy cheap in hopes of a bull market in Canadian cannabis?
European Connections & Homegrown Losses
Shorting Aurora Again
Canada’s small population and relatively small cannabis market do not justify a large number of large producers. So, like in 2018, Aurora sells investors on the potential in Europe. Aurora is one of the few Canadian companies with a licence to grow in Germany.
And with Germany likely to legalize it by the end of the year, this could certainly boost the value of Aurora’s shares.
Regardless of when or how Germany legalizes, Aurora still has problems at home. Its infamous “Sky” facility in Alberta closed its doors despite being hyped as a pioneer in cannabis cultivation just a few years ago.
Aurora also announced net losses of $1 billion in its third quarter. The company’s third-quarter financial and operational results saw a 17% sequential decrease in revenue to $50.4 million.
“If you take a look at the top players in Canada, take a look at where their stock prices are compared to where their all-time highs were, and we’re taking a look at losses 99 cents on the dollar,” says Nawan Butt, Portfolio Manager at Purpose Investments. “It’s all to the determent of the equity holder for the LPs.
And I’m surprised more equity holders aren’t appalled at some of the decisions management have taken.”
Of course, equity holders probably are appalled at Aurora, hence why the company is laying off 12% of its workforce on a plan to cut $90 million in costs.
Shorting Aurora Based on Negative Cashflows
The problem for Aurora Cannabis and many other large LPs is that they’ve never had positive cash flow. Governments and media like to promote Environmental, Social, Governance (ESG) ratings to determine whether a company is “really” profitable. But this obvious woke progressive nonsense.
All that matters is positive cash flow, which is a problem for Aurora. From last July to March this year, Aurora used $83 million to fund its day-to-day operations.
This past June, Aurora raised $172.5 million through offering stock. Investors have every reason to be worried about dilution.
Is it time to short Aurora again? In 2018, Aurora was trading 28 times higher than it should be, considering its earnings before interest, taxes, depreciation, and amortization. Today, Aurora is trading 1.7 times the revenue it earns from selling cannabis.
Canopy is in a worse position, with investors paying 3.6 times revenue.
German legalization may boost their stock performance as Canadian legalization did. But that boost was short-lived because the company’s fundamentals are too risky.
The fundamentals of Canada’s legalization scheme are unsound. Throw an economic depression into the mix (the consequence of excessively low-interest rates, not the “psychology” of the masses), and it’s a perfect storm.
It’s probably time to be shorting Aurora again.
"DE" / 'consultationsprozess cannabis' - live stream / https://www.bundesdrogenbeauftragter.de/cannabis-aber-sicher/
https://www.youtube.com/channel/UCc0jxDa7R3NeqevrBkNjk0w (deutscher Stream)
https://www.youtube.com/channel/UChpAIBBNNEFf4GFFDuUke4w (englischer Stream)
"ntv" tv channel (DE). live "pr" from lauterbach comming in 10 minutes about controlled release of canabis in germany
And none of that has anything to do with the movements of ACB.
It's no wonder your previous prediction was so off base.
Who are the Manipulators, and who are the criminals control all day every day and non stop of fkn up stocks, all kinds of stocks. Well, there is no one person or entity, but numerous of them..!..
take for example this JPM thugs!?...Gold man thugs, the list goes on and on and on, but remember fed, the largest power house that is behind all the manipulations...!. if they want they can make market green or red or whatever the fk direction they wanted to take it to.
Check this:
Explainer-How a massive options trade by a JP Morgan fund can move markets
Stock Markets 1 hour ago (Jun 28, 2022 01:56PM ET)
https://www.investing.com/news/stock-market-news/explainerhow-a-massive-options-trade-by-a-jp-morgan-fund-can-move-markets-2841849
those are legit questions...!
we will re-visit these topics you raised sometime soon, and why it would change will be explained at that time..!!..in the meantime, chill out and wait for the expected (as per my post)..!
That's more great news!
You are saying the 99% drop in price is cause by "manipulators" and not things like:
*) Declining revenue
*) Declining margin
*) Declining market share
*) Billions of write-offs
*) Management lies
*) Focus on phony "adjusted EBITDA" numbers
*) Constant dilution
*) Bonuses based on taking money from shareholders
Why do "things got to change"?
Read my post again, it has the answer, the whole fkn sector is constantly, consistently crashed down by so many manipulators.....everything has a limit and things got to change..!.
Aurora Cannabis and the entire sector breakout alert!!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169257170
ACB was never worth as much as it was on the day of Canadian legalization... a huge milestone pumped by Aurora.. insiders quickly sold off making tons of profit at the peak. Who bought these shares? The deceived...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144452321
Yep. Have to have the grace periods to pump it for executives to get out and leave the bag holders behind.
30 consecutive trading days with a closing bid price under $1
Then they get up to two 180 day grace periods.
They have to do a reverse split to stay on the nasdaq if this goes below $1 for any length of time. I think the rules are 1 month.
I see they have a few insiders purchasing shares. Might be a little too late, but I guess better than never.
every dog has its day.......next couple months gonna get interesting .
LP,s will sell a safe product... not!
Outbreak by Organigram
LAWS PASSED IN NEW BRUNSWICK AFTER ORGANIGRAM OUTBREAK
TRAVIS CESARONEJUNE 7, 2022
To Bonno
Sixteen people fell seriously ill with a severe form of pneumonia in 2019 and one man died. New Brunswick Health shelved any response to the outbreak caused by Organigram for months before laws finally passed.
An Outbreak Caused by Organigram Cooling Facility
In the beginning, the Health Ministry disregarded Organigram’s infectious cloud. The bacteria that did spread across Moncton, New Brunswick originated from a cooling tower atop a new section of the licensed cannabis producer’s warehouse. The tower contains a fan and water, which grew excessive quantities of Legionella bacteria — external of the facility.
And while OGI admitted to fault one-a-half years later, in December of 2020 — Legionella tests had yet to be mandated. Responding to international criticisms in September 2021, though, New Brunswick’s Minister of Health, Dorothy Shephard announced that mandatory testing would be put into force by this Spring.
One correspondence and two new laws
Mandates were first announced this Spring — eight days after Minister Shephard replied to thank this author for an email. Cited in the correspondence was a recent peer-reviewed study published in the Journal of Alzheimer’s Association. (1) Unrelated to Legionella, the email documented a potential link between research pursued by OGI and a separate epidemic that NB Public Health spent two years investigating.
Unusual neurological ailments occurred across New Brunswick from 2019 to 2021. Causing a false alarm, the cases were misdiagnosed as a single unknown disease. Albeit no proof has been released, the potential link sent to Minister Shephard correlated research pursued by OGI with a hypothetical Alzheimer’s Disease outbreak. And according to autopsies, most of the unusual neurological cases included known ailments such as Alzheimer’s Disease.
Outbreak by Organigram
Some cases identified in New Brunswick between 2019 to 2021 were considered simple misdiagnoses in the final report. The location of OGI, a Moncton-based producer, is highlighted in red.
Bill 104
Separately, an additional amendment to the Public Health Act in New Brunswick was introduced on May 10 this year. Covering emergencies beyond just the Organigram outbreak, the law under Bill 104 passed the third reading on June 2, 2022.
During the pandemic, mandates had to be placed on individuals rather than buildings or businesses. A virtue for gym owners providing a haven from mask restrictions. At the same, negligent companies responsible for outbreaks were given a curtain of protection. New revisions to the act under Bill 104, therefore, intend to rip down that curtain. Now, powers previously only granted under the Emergency Act can be used by the Health Minister during any serious health emergency.
Public Health Officers will be allowed to force specific businesses or buildings to follow mandates — or shut down — in the event of a future unsolved outbreak. And while Covid-19 outbreaks are covered, the new revisions are generalized for any public health emergency. Interestingly, Bill 104 can be used if Legionnaire’s or an unsolved neurological disease continues to spread throughout the province, for example.
Let us know in the comments what you think caused the neurodegenerative diseases. And don’t forget to read more about the potential link between Organigam and an Alzheimer’s Disease outbreak.
Show your work
Tau proteins, which are tran-seeded by prions found in Saccharomyces cerevisiae, only aggregate Alzheimer’s Disease.
Accumlation of tau in genetically predisposed individuals leads to Alzheimer’s onset after approximately six years. (3)
Parkinson’s and Lewy Body Dementia, also noted in GNB’s final report, are caused by different proteins, such as beta-amyloid and alpha-synuclein.
Yeast can be genetically engineered to produce both proteins for researching neurodegenerative diseases and cell death. (4) This induces cytotoxicity, although to use this yeast model as a control in the R&D phase of cannabinoid production would be unorthodox.
Sources
Bonno, Flach, M., Leu, C., Martinisi, A., Skachokova, Z., Frank, S., Tolnay, M., Stahlberg, H., & Winkler, D. T. (2022). Trans-seeding of Alzheimer-related tau protein by a yeast prion. Alzheimer’s & dementia : the journal of the Alzheimer’s Association, 10.1002/alz.12581. Advance online publication.
Communication with The Honourable Dorothy Shephard. March 21, 2022.
Guzmán-Vélez E, Diez I, Schoemaker D, et al. Amyloid-ß and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease. Proc Natl Acad Sci U S A. 2022;119(15):e2113641119. doi:10.1073/pnas.2113641119
Sampaio-Marques B, Bonno, Felgueiras C, Silva A, et al. SNCA (a-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy. Autophagy. 2012;8(10):1494-1509. doi:10.4161/auto.21275
Lawsuit? ACB management are experts at fleecing the shareholders and then telling them how good it is for shareholder value. lol
What they say: Great cash balance
What they mean: Thank you shareholders for the cash DILUTE DILUTE DILUTE
What they say: Adjusted EBITDA positive in the future
What they mean: We hope enough shareholders are dumb enough to care about this bogus measurement DILUTE DILUTE DILUTE
What they say: We want to increase shareholder value
What they mean: We don't give a damn about shareholders. DILUTE DILUTE DILUTE
It's a drop in the bucket but at first glance Chitwant Kohli purchased shares yesterday. ?Not given? I'm at work right now but someone might be able to see if he really did purchase vs given these shares.
Yeah, I was a bit pissed off when I read "general purpose" myself. Hopefully we find out the real use for this cash soon so all these assumptions get cleared up... ugly or not ugly. If this really is for bonuses I have a hunch lawsuit will follow, but not sure if they have enough of a case to win or settle out of court.
Don't forget they are aided by those who say things like:
*) Don't believe the numbers, believe what management tells you to believe
*) Sins of the past are gone
Too funny
Followers
|
894
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
70346
|
Created
|
11/09/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |